title: In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
abstract: OBJECTIVE
  Increasing resistance of pathogenic bacteria to antibiotics is a severe problem in health care and has intensified the search for novel drugs. Cationic antibacterial peptides are the most abundant antibiotics in nature and have been frequently proposed as new anti-infective agents. Here, a group of diastereomeric (containing d- and l-amino acids) peptides is studied regarding their potency against multiply resistant clinical isolates and their modes of action against Gram-positive cocci.
  
  
  METHODS
  MIC determinations and chequerboard titrations followed established procedures. Mode of action studies included killing kinetics and a series of experiments designed to characterize the impact of the diastereomeric peptides on bacterial membranes.
  
  
  RESULTS
  The tested diastereomers displayed high antimicrobial and broad spectrum activity with amphipathic-2D being the most active peptide. Synergic activities were observed with individual strains. Mode of action studies clearly demonstrated that the cytoplasmic membrane is a primary target for the peptides and that membrane disruption constitutes a significant bactericidal activity for the major fraction of a bacterial population. However, depending on the indicator strain, the results also suggest that additional molecular events contribute to the overall activity.
authors.affiliation: Institut für Medizinische Mikrobiologie und Immunologie der Universität Bonn, D-53105 Bonn, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Pag
authors.forename: M
authors.initials: M
authors.lastname: Oedenkoven
authors.forename: N
authors.initials: N
authors.lastname: Papo
authors.forename: Z
authors.initials: Z
authors.lastname: Oren
authors.forename: Y
authors.initials: Y
authors.lastname: Shai
authors.forename: H-G
authors.initials: HG
authors.lastname: Sahl
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000382:microbiology*; D003470:Culture Media; D003593:Cytoplasm / Q000502:physiology; D004357:Drug Synergism; D005470:Fluorometry; D005658:Fungi / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D007425:Intracellular Membranes / Q000502:physiology; D007700:Kinetics; D008564:Membrane Potentials / Q000502:physiology; D008826:Microbial Sensitivity Tests; D010455:Peptides; D013237:Stereoisomerism
chemical_list: D000900:Anti-Bacterial Agents; D003470:Culture Media; D010455:Peptides; D018698:Glutamic Acid